We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OZK icon
726
Bank OZK
OZK
$5.24B
$2.85M 0.01%
124,852
-8,117
-6% -$225K
RMR icon
727
The RMR Group
RMR
$323M
$2.85M 0.01%
53,697
-700
-1% -$49.5K
ILPT
728
Industrial Logistics Properties Trust
ILPT
$513M
$2.84M 0.01%
+144,216
New +$3.08M
POR icon
729
Portland General Electric
POR
$5.62B
$2.82M 0.01%
61,601
+25,200
+69% +$1.18M
ACRS icon
730
Aclaris Therapeutics
ACRS
$735M
$2.82M 0.01%
381,948
ARMK icon
731
Aramark
ARMK
$15.3B
$2.81M 0.01%
134,125
-11,357
-8% -$295K
OLLI icon
732
Ollie's Bargain Outlet
OLLI
$4.49B
$2.8M 0.01%
42,155
-50,365
-54% -$4.19M
TIP icon
733
iShares TIPS Bond ETF
TIP
$14.7B
$2.77M 0.01%
25,300
+1,090
+5% +$119K
CLLS
734
Cellectis
CLLS
$139M
$2.77M 0.01%
166,068
TSCO icon
735
Tractor Supply
TSCO
$17.3B
$2.76M 0.01%
165,270
-638,500
-79% -$11.5M
KEM
736
DELISTED
KEMET Corporation
KEM
$2.74M 0.01%
156,400
-33,800
-18% -$632K
TTD icon
737
Trade Desk
TTD
$6.95B
$2.74M 0.01%
+236,000
New +$2.95M
MSTR icon
738
Strategy Inc
MSTR
$49.4B
$2.73M 0.01%
+214,000
New +$2.71M
STAA icon
739
STAAR Surgical
STAA
$1.14B
$2.73M 0.01%
85,400
+54,000
+172% +$2.1M
VOO icon
740
Vanguard S&P 500 ETF
VOO
$1.03T
$2.7M 0.01%
11,755
CBT icon
741
Cabot Corp
CBT
$4.05B
$2.7M 0.01%
62,811
+59,111
+1,598% +$2.95M
QURE icon
742
uniQure
QURE
$2.95B
$2.68M 0.01%
+93,046
New +$2.59M
WSR
743
DELISTED
Whitestone REIT
WSR
$2.67M 0.01%
218,200
-24,100
-10% -$327K
SRI icon
744
Stoneridge
SRI
$203M
$2.67M 0.01%
108,144
-15,200
-12% -$386K
NGHC
745
DELISTED
National General Holdings Corp
NGHC
$2.65M 0.01%
109,344
+77,900
+248% +$1.98M
DCPH
746
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.64M 0.01%
125,864
TRK
747
DELISTED
Speedway Motorsports, Inc.
TRK
$2.64M 0.01%
162,289
-28,751
-15% -$474K
STLD icon
748
Steel Dynamics
STLD
$34.2B
$2.6M 0.01%
86,452
+65,400
+311% +$2.47M
EXTN
749
DELISTED
Exterran Corporation
EXTN
$2.58M 0.01%
145,650
-20,300
-12% -$455K
INXN
750
DELISTED
Interxion Holding N.V.
INXN
$2.58M 0.01%
47,556

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.